Real-time enrollment status for this acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT06137118 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 142 participants |
| Active Locations | 12 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of March 2, 2026: Clinical trial NCT06137118 is currently recruiting participants. This clinical trial study for acute lymphoblastic leukemia is actively seeking new participants at 12 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06137118 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06137118 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.